# ZhenZhun Bio-technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhenzhun-bio-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.zz-bio.com
- Total disclosed funding: $16M
- Latest round: Series A (Mar 9, 2022)
- Investors on record: 2

## About

Established in 2016 and based in Shanghai, China, ZhenZhun Bio-technology Co., Ltd. is an in vitro diagnostic instrument consumables manufacturer that focuses on the Research and development, production, sales in vitro diagnostic instrument consumables. In August 2019, the company raised an undisclosed amount in angel funding from new investor Anlongmed Investment.

The products of the company include Digital PCR System (AccuONE-100 and  AccuONE-200) which can be used in liquid tumor biopsy, non-invasive prenatal diagnosis, pathogenic microbial testing, viral load determination, copy number variation, rare mutation detection, relative gene expression studies, transgenic testing, and validation of second-generation sequencing results. The company also produced the consumable named as Master Mix.

The company will focus on the clinical registration, marketing and scale up production of micro-chip digital PCR products and development of several kits.

## Funding rounds

- Series A, Mar 9, 2022, $16M — Grand Mount Capital
- Series A, Aug 2, 2019 — AnlongMed Investment

## Investors

- AnlongMed Investment — Series A
- Grand Mount Capital (https://capitalatlas.ai/funds/grand-mount-capital) — Series A